{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:33Z","timestamp":1753891293168,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>We report a case of Beh\u00e7et\u2019s disease (BD) with a newly identified tissue factor pathway inhibitor (TFPI) gene mutation. The patient suffered from recurrent deep vein thrombosis and dural sinus thrombosis which could not be relieved by constant anticoagulation therapy. Slight relapsing oral lesion was the initial manifestation of BD but was neglected. Genital ulcers and ocular symptoms were manifest 8-month later than vascular involvement. The patient was diagnosed with BD at last and a novel mutation in TFPI was identified simultaneously. After administration with azathioprine and dexamethasone, the clinical symptoms were quickly gone and no relapse was found during 7-month follow-up.<\/jats:p>","DOI":"10.3389\/fmed.2022.873600","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T15:09:59Z","timestamp":1650380999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report and Literature Review: Beh\u00e7et\u2019s Disease With a Novel TFPI Gene Mutation"],"prefix":"10.3389","volume":"9","author":[{"given":"Jiewen","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wengang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/humu.22208","article-title":"Genetic variant on PDGFRL associated with Beh\u00e7et disease in Chinese Han populations.","volume":"34","author":"Hou","year":"2013","journal-title":"Hum Mutat."},{"key":"B2","first-page":"347","article-title":"Disease patterns of patients with Beh\u00e7et\u2019s disease demonstrated by factor analysis.","volume":"17","author":"Krause","year":"1999","journal-title":"Clin Exp Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/rheumatology\/kew486","article-title":"Exploring the variability in Beh\u00e7et\u2019s disease prevalence: a meta-analytical approach.","volume":"57","author":"Maldini","year":"2018","journal-title":"Rheumatology (Oxford)."},{"key":"B4","first-page":"133","article-title":"Beh\u00e7et\u2019s disease in patients of German and Turkish origin living in Germany: a comparative analysis.","volume":"31","author":"K\u00f6tter","year":"2004","journal-title":"J Rheumatol."},{"key":"B5","first-page":"1033","article-title":"Beh\u00e7et\u2019s disease in Israel: the influence of ethnic origin on disease expression and severity.","volume":"28","author":"Krause","year":"2001","journal-title":"J Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10067-006-0349-4","article-title":"Prevalence and clinical aspects of Behcet\u2019s disease in the north of Israel.","volume":"26","author":"Krause","year":"2007","journal-title":"Clin Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10067-013-2205-7","article-title":"Major vascular involvement in Beh\u00e7et\u2019s disease: a retrospective study of 796 patients.","volume":"32","author":"Fei","year":"2013","journal-title":"Clin Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","article-title":"Vascular involvement in Beh\u00e7et\u2019s syndrome: a retrospective analysis of associations and the time course.","volume":"53","author":"Tascilar","year":"2014","journal-title":"Rheumatology (Oxford)."},{"key":"B9","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor.","volume":"123","author":"Wood","year":"2014","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2741\/3926","article-title":"Tissue factor pathway inhibitor: structure-function.","volume":"17","author":"Broze","year":"2012","journal-title":"Front Biosci (Landmark Ed)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1160\/TH14-12-1043","article-title":"Genetic determinants of tissue factor pathway inhibitor plasma levels.","volume":"114","author":"Dennis","year":"2015","journal-title":"Thromb Haemost."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1182\/blood-2012-05-432005","article-title":"Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S.","volume":"120","author":"Ahnstr\u00f6m","year":"2012","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/jth.13665","article-title":"Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitor\u03b1, and protein S.","volume":"15","author":"Dahlb\u00e4ck","year":"2017","journal-title":"J Thromb Haemost."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1111\/jth.13431","article-title":"Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.","volume":"14","author":"Dennis","year":"2016","journal-title":"J Thromb Haemost."},{"key":"B15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3349\/ymj.2012.53.1.35","article-title":"New insights in the clinical understanding of Beh\u00e7et\u2019s disease.","volume":"53","author":"Cho","year":"2012","journal-title":"Yonsei Med J."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-02931-1","article-title":"Pulmonary artery thrombosis as the first presentation of Beh\u00e7et\u2019s syndrome: a case report and review of the literature.","volume":"15","author":"Alakkas","year":"2021","journal-title":"J Med Case Rep."},{"key":"B17","first-page":"808","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome.","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/art.34450","article-title":"Immunosuppressants reduce venous thrombosis relapse in Beh\u00e7et\u2019s disease.","volume":"64","author":"Desbois","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","article-title":"Treatment of venous thrombosis associated with Behcet\u2019s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation.","volume":"27","author":"Ahn","year":"2008","journal-title":"Clin Rheumatol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1756-185X.13298","article-title":"Management of vascular Beh\u00e7et\u2019s disease.","volume":"22","author":"Alibaz-Oner","year":"2019","journal-title":"Int J Rheum Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1160\/TH09-10-0693","article-title":"Total tissue factor pathway inhibitor and venous thrombosis. the longitudinal investigation of thromboembolism etiology.","volume":"104","author":"Zakai","year":"2010","journal-title":"Thromb Haemost."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1161\/01.CIR.0000120705.55512.EC","article-title":"Endothelial cell markers and the risk of coronary heart disease: the prospective epidemiological study of myocardial infarction (PRIME) study.","volume":"109","author":"Morange","year":"2004","journal-title":"Circulation."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014978","article-title":"Association of TFPI polymorphisms rs8176592, rs10931292, and rs10153820 with venous thrombosis: a meta-analysis.","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine (Baltimore)."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.873600\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T15:10:09Z","timestamp":1650381009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.873600\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":23,"alternative-id":["10.3389\/fmed.2022.873600"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.873600","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"article-number":"873600"}}